Role of health technology assessment in pharmaceutical market access in developed countries
Kahveci, Rabia and Oortwijn, Wija and Godman, Brian and Meltem Koç, E. and Tibet, Birol; Wertheimer, Albert I. and Kockaya, Guvenc, eds. (2018) Role of health technology assessment in pharmaceutical market access in developed countries. In: Pharmaceutical Market Access in Developed Markets. SEEd Medical Publishers, Italy, pp. 225-256. ISBN 8897419739
|
Text (Kahveci-etal-SEEd-2017-Role-of-health-technology-assessment-in-pharmaceutical)
Kahveci_etal_SEEd_2017_Role_of_health_technology_assessment_in_pharmaceutical.pdf Final Published Version Download (780kB)| Preview |
Abstract
Introduction and use of a health technology in a health care setting has clinical, economic, as well as organizational, social-cultural, legal and ethical impacts. Health Technology Assessment (HTA) is a multidisciplinary field that addresses these impacts, considering healthcare context as well as available alternatives. HTA mainly aims to inform policy and clinical decision making. While systematically evaluating the effects of the health technology, HTA addresses direct and intended effects as well as the indirect and unintended effects. It is a multidisciplinary field with well-developed systematic processes and methods
Creators(s): | Kahveci, Rabia, Oortwijn, Wija, Godman, Brian, Meltem Koç, E. and Tibet, Birol; Wertheimer, Albert I. and Kockaya, Guvenc | Item type: | Book Section |
---|---|
ID code: | 61921 |
Keywords: | health technology, pharmaceutical markets, developing countries, Pharmacy and materia medica, Pharmacology, Toxicology and Pharmaceutics(all) |
Subjects: | Medicine > Pharmacy and materia medica |
Department: | Faculty of Science > Strathclyde Institute of Pharmacy and Biomedical Sciences |
Depositing user: | Pure Administrator |
Date deposited: | 03 Oct 2017 15:40 |
Last modified: | 25 Jan 2021 04:15 |
Related URLs: | |
URI: | https://strathprints.strath.ac.uk/id/eprint/61921 |
Export data: |